Synapse - Genitourinary Oncology Service

Results (42)

Immuno-oncologyDupilumab for bullous pemphigoid related to immune checkpoint inhibitors: A retrospective case series

Journal Article

Nykaza, I.; Moy, A.; Dusza, S. W.; Moskowitz, A.; Iyer, G.; Iqbal, A.; Motzer, R.; Ilson, D. H.; O'Cearbhaill, R. E.; Kazi, R.; more...
The Oncologist (2025)

Fulltext@MSK | Save

Phase 1b/2 study of batiraxcept alone and in combination with cabozantinib with or without nivolumab for advanced clear cell renal cell carcinoma

Journal Article

Beckermann, K. E.; Shah, N. J.; Campbell, M. T.; Haas, N. B.; Nelson, A.; Ornstein, M. C.; Mao, S.; Keshava-Prasad, H. S.; Hammers, H.; Gao, X.; more...
The Oncologist (2025)

Fulltext@MSK | Save

Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors

Journal Article

Nykaza, I.; Murciano-Goroff, Y. R.; Desilets, A.; Harada, G.; Postow, M. A.; Callahan, M. K.; Lee, C. H.; Rudin, C. M.; Kelsen, D. P.; Stadler, Z. K.; more...
The Oncologist (2025)

Fulltext@MSK | Save

Reevaluating the role of platinum-based chemotherapy in the evolving treatment landscape for patients with advanced urothelial carcinoma

Review

Zhang, T.; Tan, A.; Shah, A. Y.; Iyer, G.; Morris, V.; Michaud, S.; Sridhar, S. S.
The Oncologist (2024)

Fulltext@MSK | Save

Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapy

Journal Article

Cowzer, D.; Chou, J. F.; Walch, H.; Keane, F.; Khalil, D.; Shia, J.; Do, R. K. G.; Yarmohammadi, H.; Erinjeri, J. P.; El Dika, I.; more...
The Oncologist (2024)

Fulltext@MSK | Save

Real-world treatment patterns and clinical outcomes of metastatic renal cell carcinoma patients post immune-oncology (IO) and vascular endothelial growth factor (VEGF) receptor targeted therapies

Meeting Abstract

Shah, N.; Sura, S.; Shinde, R.; Wentworth, C.; Conkling, P.; Bupathi, M.; Perini, R.; Vickery, D.; Motzer, R.
The Oncologist (2024)

Fulltext@MSK | Save

A phase 1b, open-label, safety, tolerability, and efficacy study of HC-7366 in combination with belzutifan (WELIREG(TM)) in patients with advanced or metastatic renal cell carcinoma, NCT06234605

Meeting Abstract

McKay, R. R.; Garmezy, B.; Barata, P.; Ornstein, M.; Shah, N. J.; Hammers, H.; Hutson, T. E.; Chisamore, M.; Karim, D.; Mattson, P.; more...
The Oncologist (2024)

Fulltext@MSK | Save

Nivolumab plus ipilimumab vs sunitinib for first-line treatment of advanced renal cell carcinoma: 8-year follow-up with analyses in favorable risk patients from the phase 3 CheckMate 214 trial

Meeting Abstract

Atkins, M. B.; Escudier, B.; McDermott, D. F.; Burotto, M.; Choueiri, T. K.; Hammers, H. J.; Plimack, E. R.; Porta, C.; George, S.; Powles, T.; more...
The Oncologist (2024)

Fulltext@MSK | Save

The relationship between health-related quality of life and overall survival in patients with advanced renal cell carcinoma in CheckMate 214

Journal Article

Cella, D.; Choueiri, T. K.; Hamilton, M.; Blum, S. I.; Ivanescu, C.; Karu, K.; Ejzykowicz, F.; Motzer, R. J.
The Oncologist (2024)

Fulltext@MSK | Save

Commercial versus medicaid insurance and use of high-priced anticancer treatments

Journal Article

Mitchell, A. P.; Kinlaw, A. C.; Peacock-Hinton, S.; Dusetzina, S. B.; Winn, A. N.; Sanoff, H. K.; Lund, J. L.
The Oncologist (2024)

Fulltext@MSK | Save